Occurrence of sialic acids in healthy humans and different disorders

European Journal of Clinical Investigation

Volumn 29, Issue 5, 1999, Pages 413-425

  Sillanaukee, P ^a,b,c,d,f   Ponnio M ^a   Jaaskelainen I P ^e  

^a PFIZER INC   (United States)

^b UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

^c KAROLINSKA INSTITUTE   (Sweden)

^d TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^f Pharmacia & Upjohn AB   (Sweden)

Author keywords

Cancer; Coronary heart disease; Diabetes; Inflammatory diseases; Neuraminic acid; Sialic acids

Indexed keywords

GLYCOPROTEIN; NEURAMINIC ACID; SIALIC ACID DERIVATIVE;

AGING; ALCOHOL ABUSE; ARTICLE; BIOASSAY; BLOOD LEVEL; CANCER; CARBOHYDRATE METABOLISM; CHRONIC GLOMERULONEPHRITIS; CHRONIC KIDNEY FAILURE; CORRELATION FUNCTION; DIABETES MELLITUS; DISORDERS OF CARBOHYDRATE METABOLISM; HUMAN; INFLAMMATORY DISEASE; ISCHEMIC HEART DISEASE; MORTALITY; PREGNANCY; PRIORITY JOURNAL; SMOKING; STROKE;

EID: 0032893557     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1999.00485.x     Document Type: Article

References (123)

1. 1 Varki A. Diversity in the sialic acids. Glycobiology 1992; 2: 25-40.
2. 2 Reuter G, Gabius HJ. Sialic acids structure-analysis-metabolism-occurrence-recognition. Biol Chem Hoppe Seyler 1996; 377: 325-42.
3. 3 Taniuchi K, Chifu K, Hayashi N, et al. A new enzymatic method for the determination of sialic acid in serum and its application for a marker of acute phase reactants. Kobe J Med Sci 1981; 27: 91-102.
4. 4 Petren S, Vesterberg O. The N-acetylneuraminic acid content of five forms of human transferrin. Biochim Biophys Acta 1989; 994: 161-5.
5. 5 Schauer R, Kelm S, Reuter G, Roggentin P, Shaw L. Biochemistry and role of sialic acids. In: Rosenberg A, editor. Biology of the sialic acids. New York: Plenum; 1995.
6. 6 Waters PJ, Lewry E, Pennock CA. Measurement of sialic acid in serum and urine: clinical applications and limitations. Ann Clin Biochem 1992; 29: 625-37.
7. 7 Crook M. The determination of plasma or serum sialic acid. Clin Biochem 1993; 26: 31-8.
8. 8 Klenk E, Langerbieins H. Orcinol method for measuring sialic acid. Hoppe Seyler's Z, Physiol Chem 1941; 270: 185-93.
9. 9 Svennerholm L. Quantitative estimation of sialic acids. Biochim Biophys Acta 1957; 24: 604-11.
10. 10 Miettinen T, Takki-Luukkainen IT. Use of butyl acetate in determination of sialic acid. Acta Chem Scand 1959; 13: 856-8.
11. 11 Svennerholm L. Assays of sialic acids. Methods Enzymol 1963; 6: 459-62.
12. 12 Jourdian GW, Dean L, Roseman S. The sialic acids. A periodate-resorcinol method for the quantitative estimation of free sialic acids and their glycosides. J Biol Chem 1971; 246: 430-5.
13. 13 Svennerholm L. Quantitative estimation of sialic acids. Acta Chem Scand 1958; 12: 547-54.
14. 14 Aminoff D. The determination of free sialic acid in the presence of the bound compound. Virology 1959; 7: 355-7.
15. 15 Warren L. The thiobarbituric acid assay of sialic acids. J Biol Chem 1959; 234: 1971-5.
16. 16 Durand G, Feger J, Coignoux M, Agneray J, Pays M. Rapid Estimation of small amounts of formaldehyde liberated during periodate oxidation of a sialoglycoprotein. Anal Biochem 1974; 61: 232-6.
17. 17 Krantz MJ, Lee YC. A sensitive autoanalytical method for sialic acids. Anal Biochem 1975; 63: 464-9.
18. 18 Brunetti P, Swanson A, Roseman A. Assay of sialic acids. Methods Enzymol 1963; 6: 465-73.
19. 19 Teshima S, Tamai K, Hayashi Y, Emi S. New enzymatic determination of sialic acid in serum. Clin Chem 1988; 34: 2291-4.
20. 20 Simpson H, Chusney GD, Crook MA, Pickup JC. Serum sialic acid enzymatic assay based on microtitre plates: application for measuring capillary serum sialic acid concentrations. Br J Biomed Sci 1993; 50: 164-7.
21. 21 Crook M, Haq M, Tutt P. Evaluation of three assays for the determination of serum total sialic acid. Clin Biochem 1993; 26: 449-54.
22. 22 Katopodis N, Stock CCH. Improved method to determine lipid bound sialic acid in plasma or serum. Res Commun Chem Pathol Pharmacol 1980; 30: 171-80.
23. 23 Vegh Z, Kremmer T, Boldizsar M, Gesztesi KA, Szajani B. A re-evaluation of the lipid-bound sialic acid determination. Clin Chim Acta 1991; 203: 259-68.
24. 24 Kamerling JP, Makovitzky J, Schauer R, Vliegenthart JFG, Wember M. The nature of sialic acids in human lymphocytes. Biochimica et Biophysica Acta 1982; 714: 351-5.
25. 25 Li K. Determination of sialic acid in human serum by reverse phase liquid chromatography with fluorimetric detection. J Chromatogr 1992; 579: 209-13.
26. 26 Haverkamp J, van-Halbeck H, Dorland L, Vliegenthart JF, Pfeil R, Schauer R. High-resolution 1H-NMR spectroscopy of free and glycosidically linked O-acetylated sialic acids. Eur J Biochem 1982; 122: 305-11.
27. 27 Sata T, Roth J, Zuber C, Stamm B, Heitz PU. Expression of alpha 2,6 linked sialic acid residues in neoplastic but not in normal human colonic mucosa. A lectin-gold cytochemical study with Sambucus nigra and Maackia amurensis lectins. Am J Pathol 1991; 139: 1435-48.
28. 28 Zimmer G, Suguri T, Reuter G, Yu RK, Schauer R, Herrler G. Modification of sialic acids by 9-O-acetylation is detected in human leucocytes using the lectin property of influenza C virus. Glycobiology 1994; 4: 343-9.
29. 29 Kawamura A, Kijima-Suda I, Sugimoto M, et al. A monoclonal antibody to free N-acetylneuraminic acid. Biochim Biophys Acta 1990; 1033: 201-6.
30. 30 Corfield AP, Wember M, Schauer R, Rott R. The specificity of viral sialidases. The use of oligosaccharide substrates to probe enzymic characteristics and strain-specific differences. Eur J Biochem 1982; 124: 521-5.
31. 31 Haverkamp J, Schauer R, Wember M. Neuraminic acid derivates newly discovered in humans. Hoppe Seyler's Z Physiol Chem 1976; 357: 1699-705.
32. 32 Kundu SK, Diego I, Osovitz S, Marcus DM. Glycosphingo-lipids of human plasma. Arch Biochem Biophys 1985; 238: 388-400.
33. 33 Senn HJ, Orth M, Fitzke E, Wieland H, Gerok W. Gangliosides in normal human serum. Concentration, pattern and transport by lipoproteins. Eur J Biochem 1989; 181: 657-62.
34. 34 Lindberg G, Rastam L, Gullberg B, Eklund GA, Tornberg S. Serum sialic acid concentration and smoking: a population based study. BMJ 1991; 303: 1306-7.
35. 35 Crook MA, Treloar A, Haq M, Tutt P. Serum total sialic acid and acute proteins in elderly subjects. Eur J Clin Chem Clin Biochem 1994; 32: 745-7.
36. 36 Crook M, Collins D, Lumb P, Fogelman I, Treloar A. The relationship between the female menopause and serum sialic acid, a known cardiovascular risk factor. Eur J Obstet Gynecol Reprod Biol 1998; 76: 185-7.
37. 37 Lindberg G, Iso H, Rastam L, Lundblad A, Folsom AR. Serum sialic acid and its correlates in community samples from Akita, Japan and Minneapolis, USA. Int J Epidemiol 1997; 26: 58-63.
38. 38 Khadapkar SV, Sheth NA, Bhide SV. Independence of sialic acid levels in normal and malignant growth. Cancer Res 1975; 35: 1520-3.
39. 39 Alvi MH, Amer NA, Sumerin I. Serum 5-nucleotidase and serum sialic acid in pregnancy. Obstet Gynecol 1988; 72: 171-4.
40. 40 Waters PJ, Lewry E, Brimble AP, Pennock CA. Factors affecting the assay of urinary free and bound sialic acid. Biochem Soc Trans 1992; 20: 366S.
41. 41 Fang-Kircher SG. Comparison of sialic acids excretion in spot urines and 24-hour-urines of children and adults. Eur J Clin Chem Clin Biochem 1997; 35: 47-52.
42. 42 Suzuki K. Sialic acid in biochemical pathology. In: Rosenberg, A ed. Biology of the sialic acids. New York: Plenum; 1995.
43. 43 Sewell AC, Poets CF, Degen I, Stöss H, Pontz BF. The spectrum of free neuraminic acid storage in childhood: clinical, morphological and biochemical observations in three non-Finnish patients. Am J Med Genet 1996; 63: 203-8.
44. 44 Seppälä R, Tietze F, Krasnewich D, et al. Sialic acid metabolism in sialuria fibroblasts. J Biol Chem 1991; 266: 7456-61.
45. 45 Krasnewich DM, Tietze V, Krause W, et al. Clinical and biochemical studies in an American child with sialuria. Bio chem Med Metab Biol 1993; 49: 90-6.
46. 46 Fabricius T, Scott DM, Kinne RK. Rabbit urinary tammhorsfall glycoprotein. Chemical composition and tentative carbohydrate structure. Biol Chem Hoppe Seyler 1989; 370: 151-8.
47. 47 Yoshimura K, Yoshioka T, Miyake O, Honda M, Koide T, Okuyama A. Investigation of the possible role of sialic acid in calcium oxalate urolithiasis. Eur Urol 1998; 33: 111-5.
48. 48 Imam A, Laurence DJ, Neville AM. Isolation and characterization of a major glycoprotein from milk-fat-globule membrane of human breast milk. Biochem J 1981; 193: 47-54.
49. 49 Corfield AP, Wagner SA, Safe A, et al. Sialic acids in human gastric aspirates: detection of 9-O-lactyl-and 9-O-acetyl-N-acetylneuraminic acids and a decrease in total sialic acid concentration with age. Clin Sci 1993; 84: 573-9.
50. 50 Mezzano D, Aranda E, Garcia ME, Pereira J, Quiroga T, Perez M. Total sialic acid in human and canine platelets does not change with the platelet age. Am J Hematol 1992; 40: 5-11.
51. 51 Marshall P, Hasegawa A, Davidson EA, Nussenzweig V, Whitlow M. Interaction between complement proteins C5b-7 and erythrocyte membrane sialic acid. J Exp Med 1996; 184: 1225-32.
52. 52 Schutter EM, Visser JJ, van Kemp GJ, et al. The utility of lipid-associated sialic acid (LASA or LSA) as a serum marker for malignancy. A review of the literature. Tumour Biol 1992; 13: 121-32.
53. 53 Popova GM, Promyslov MS. Level of lipid-bound sialic acids in blood from brain tumour patients. Voprosy Meditsinskoi Khimii 1995; 41: 43-5.
54. 54 Gatchev O, Rastam L, Lindberg G, Gullberg B, Eklund GA, Tornberg S. Tumours of the central nervous system and serum sialic acid concentration in men and women. Br J Cancer 1993; 68: 425-7.
55. 55 Kokoglu E, Sonmez H, Uslu E, Uslu I. Sialic acid levels in various types of cancer. Cancer Biochem Biophys 1992; 13: 57-64.
56. 56 Patel PS, Adhvaryu SG, Balar DB, Parikh BJ, Shah PM. Clinical application of serum levels of sialic acid, fucose and seromucoid fraction as tumour markers in human leukemias. Anticancer Res 1994; 14: 747-52.
57. 57 O'Kennedy R, Berns G, Moran E, et al. A critical analysis of the use of sialic acid determination in the diagnosis of malignancy. Cancer Lett 1991; 58: 91-100.
58. 58 Vivas I, Spagnuolo L, Palacios P. Total and lipid-bound serum sialic acid as markers for carcinoma of the uterine cervix. Gynecol Oncol 1992; 46: 157-62.
59. 59 Klapan I, Katic V, Culo F, et al. Lipid-bound sialic acid, prostaglandin E and histamine in head and neck cancer. Eur J Cancer 1993; 29a: 839-45.
60. 60 Polivkova J, Vosmikova K, Horak L. Utilization of determining lipid-bound sialic acid for the diagnosis and further prognosis of cancer. Neoplasma 1992; 39: 233-6.
61. 61 Imecik O, Ozer F. Diagnostic value of sialic acid in malignant pleural effusions. Chest 1992; 102: 1819-22.
62. 62 Xing RD, Wang ZS, Li CQ, Tang QY, Jiang CB, Zhang YZ. Total sialic acid as a tumor marker for oral cancer. Int J Biol Markers 1994; 9: 239-42.
63. 63 Reintgen DS, Cruse CW, Wells KE, Saba HI, Fabri PJ. The evaluation of putative tumor markers for malignant melanoma. Ann Plast Surg 1992; 28: 55-9.
64. 64 Romppanen J, Eskelinen M, Tikanoja S, Mononen I. Total and lipid-bound serum sialic acid in benign and malignant breast disease. Anticancer Res 1997; 17: 1249-54.
65. 65 Tewarson SL, Mittal VP, Singh M, Gupta GP. Serum sialic acid - an important cancer marker. Indian J Cancer 1993; 30: 125-31.
66. 66 Paszkowska A, Berbec H, Semczuk A, Cybulski M. Sialic acid concentration in serum and tissue of endometrial cancer patients. Eur J Obstet Gynecol Reprod Biol 1998; 76: 211-5.
67. 67 Bhatavdekar JM, Patel DD, Vora HH, Balar DB. Squamous cell carcinoma antigen and protein-bound sialic acid in the management of head and neck cancer. Int J Biol Markers 1991; 6: 237-40.
68. 68 Akcay T, Konukoglu D, Erosenci A, Ataus S, Dirican A, Uygur C. Urinary excretion of sialic acid in patients with superficial bladder tumors. Cancer Lett 1994; 78: 7-9.
69. 69 Bhatavdekar JM, Vora HH, Patel DD. Serum sialic acid forms as markers for head and neck malignancies. Neoplasma 1988; 35: 425-34.
70. 70 Painbeni T, Gamelin E, Cailleux A, et al. Plasma sialic acid as a marker of the effect of the treatment on metastatic colorectal cancer. Eur J Cancer 1997; 33: 2216-20.
71. 71 Shimada I, Shoji M, Futatsuya R, et al. Elevation of ratio of urinary N-acetylneuraminlactose to free sialic acid in some advanced cancer patients. J Gastroenterol 1995; 30: 21-7.
72. 72 Cyopick P, Culliton R, Brockhausen I, Sutherland DR, Mills GB, Baker M. Role of aberrant sialylation of chronic myeloid leukemia granulocytes on binding and signal transduction by chemotactic peptides and colony stimulating factors. Leuk Lymphoma 1993; 11: 79-90.
73. 73 Narayanan S. Sialic acid as a tumor marker. Ann Clin Lab Sci 1994; 24: 376-84.
74. 74 Kokoglu E, Uslu E, Uslu I, Hatemi HH. Serum and tissue total sialic acid as a marker for human thyroid cancer. Cancer Lett 1989; 46: 1-5.
75. 75 Schwick HG, Haupt H. Properties of acute phase proteins of human plasma. Behring Inst Mitt 1986; 80: 1-10.
76. 76 Dogan H, Pasaoglu H, Ekinciler OF, Tatlisen N. A comparative study of total protein, total and lipid associated serum sialic acid levels in patients with Behcet's disease and control groups. Acta Ophthalmol 1992; 70: 790-4.
77. 77 Kriat M, Vion-Dury J, Fayre R, et al. Variations of plasma sialic acid and N-acetylglucosamine levels in cancer, inflammatory diseases and bone marrow transplantation: a proton NMR spectroscopy study. Biochimie 1991; 73: 99-104.
78. 78 Mendall MA, Patel P, Asante M, et al. Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease. Heart 1997; 78: 273-7.
79. 79 Baumann H, Gauldie J. The acute phase response. Immunol Today 1994; 15: 74-80.
80. 80 Tajiri J, Noguchi S, Morita M, Tamaru M, Murakami T, Murakami N. Serum sialic acid levels in the diagnosis and follow-up of subacute granulomatous thyroiditis. Endocr J 1993; 40: 83-7.
81. 81 Baba R, Yashiro K, Nagasako K, Obata H. Significance of serum sialic acid in patients with Crohn's disease. Gastroenterologia Japonica 1992; 27: 604-10.
82. 82 Kosokai O. Clinical relevance of sialic acid determination in serum and synovial fluid in orthopaedic disorders. Japanese J Clin Pathol 1991; 39: 197-207.
83. 83 Crook MA, Haq M, Tutt P. Serum sialic acid and its relationship to various haematological parameters, including erythrocyte sedimentation rate. Br J Biomed Sci 1997; 54: 100-3.
84. 84 Lindberg G, Eklund G, Gullberg B, Rastam L. Serum sialic acid concentration and cardiovascular mortality. BMJ 1991; 302: 143-6.
85. 85 Lindberg G, Råstam L, Gullberg B, Eklund GA. Serum sialic acid concentration predicts both coronary heart disease and stroke mortality: multivariate analysis including 54385 men and women during 20.5 years of follow-up. Int J Epidemiol 1992; 21: 253-7.
86. 86 Hrncir Z, Pidrman V, Tichy M, Hamet A. Serum sialic acid in acute myocardial infarction in a dynamic follow up. Vnitrni Lekarstvi 1975; 21: 436-9.
87. 87 Succari M, Foglietti MJ, Percheron F. Perchlorosoluble glycoproteins and myocardial infarct: modifications of the carbohydrate moiety. Pathol Biol 1982; 30: 151-4.
88. 88 Crook M, Tutt P. Serum sialic acid concentration in patients with hypertriglyeridaemia. Clin Sci 1992; 83: 593-5.
89. 89 Wakabayashi I, Sakamoto K, Yoshimoto S, Masui HP. Relation of serum sialic acid to lipid concentrations. Br Med J 1992; 305: 562-3.
90. 90 Råstam L, Lindberg G, Folsom AR, Burke GL, Nilsson-Ehle P, Lundblad A. Association between serum sialic acid concentration and carotid atherosclerosis measured by B-mode ultrasound. Int J Epidemiol 1996; 25: 953-8.
91. 91 Crook MA, Tutt P, Pickup JC. Elevated serum sialic acid concentration in NIDDM and its relationship to blood pressure and retinopathy. Diabetes Care 1993; 16: 57-60.
92. 92 Pyorala K, Laakso M, Musitupa M. Diabetes and atherosclerosis: an epidemiological view. Diabetes Metab Rev 1987; 3: 463-524.
93. 93 Lindberg G, Råstam L, Gullberg B, Lundblad A, Nilsson-Ehle P, Hanson BS. Serum concentrations of total sialic acid and sialoglycoproteins in relation to coronary heart disease risk markers. Atherosclerosis 1993; 103: 123-9.
94. 94 Haq M, Haq S, Tutt P, Crook M. Serum total acid and lipid-associated sialic acid in normal individuals and patients with myocardial infarction, and their relationship to acute phase proteins. Ann Clin Biochem 1993; 30: 383-6.
95. 95 Orekhov AN, Tertov VV, Sobenin IA, et al. Sialic acid content of human low density lipoproteins affects their interaction with cell receptors and intracellular lipid accumulation. J Lipid Res 1992; 33: 805-17.
96. 96 Tertov VV, Sobenin IA, Gabbasov ZA, et al. Multiple-modified desialylated low density lipoproteins that cause intracellular lipid accumulation. Isolation, fractionation and characterization. Lab Invest 1992; 67: 665-75.
97. 97 Tertov VV, Sobenin IA, Orekhov AN. Modified (desialylated) low-density lipoprotein measured in serum by lectin-sorbent assay. Clin Chem 1995; 41: 1018-21.
98. 98 Melajärvi N, Gylling H, Miettinen TA. Sialic acids and the metabolism of low density lipoprotein. J Lipid Res 1996; 37: 1625-31.
99. 99 Crook M, Haq M, Haq S, Tutt P. Plasma sialic acid and acute-phase proteins in patients with myocardial infarction. Angiology 1994; 45: 709-15.
100. 100 Valdorf-Hansen F, Jensen T, Borch-Johnsen K, Deckert T. Cardiovascular risk factors in type 1 (insulin dependent) diabetic patients with and without proteiuria. Acta Med Scand 1987; 222: 439-44.
101. 101 Takenaka Y, Kanauchi M, Dohi Y, Dohi K, Ishikawa H. Diagnostic significance of urinary sialic acid in diabetic nephropathy. Jpn J Nephropathy 1992; 34: 85-90.
102. 102 Yokoyama H, Jensen JS, Jensen T, Deckert T. Serum sialic acid concentration is elevated in IDDM especially in early diabetic nephropathy. J Intern Med 1995; 237: 519-23.
103. 103 Crook MA, Earle K, Morocutti A, Yip J, Viberti G, Pickup JC. Serum sialic acid, a risk factor for cardiovascular disease, is increased in IDDM patients with microalbuminuria and clinical proteinuria. Diabetes Care 1994; 17: 305-10.
104. 104 Yokoyama H, Jensen JS, Myrup B, Mathiesen ER, Ronn B, Deckert T. Raised serum sialic acid concentration precedes onset of microalbuminuria in IDDM. Diabetes Care 1996; 19: 435-40.
105. 105 Crook MA, Couchman S, Tutt P. Plasma fibrinogen and its relationship to plasma sialic acid in non-insulin-dependent diabetes mellitus. Blood Coagul Fibrinolysis 1996; 7: 586-9.
106. 106 Powrie JK, Watts GF, Crook MA, Ingham JN, Taub NA, Shaw KM. Serum sialic acid and the long-term complications of insulin-dependent diabetes mellitus. Diabet Med 1996; 13: 238-43.
107. 107 Chen JW, Gall MA, Yokoyama H, Jensen JS, Deckert M, Parving HH. Raised serum sialic acid concentration in NIDDM patients with and without diabetic nephropathy. Diabetes Care 1996; 19: 130-4.
108. 108 Pickup JC, Roberts GA, Kehely AM, Pasapula C, Chusney GD, Mather HM. Higher serum sialic acid in women than in men with NIDDM. possible relevance to increased cardiovascular risk in NIDDM women (Letter). Diabetes Care 1997; 20: 1496.
109. 109 Mancini GMS, Verheijen FW, Beerens CEMT, Renlund M, Aula P. Sialic acid storage disorders: observations on clinical and biochemical variation. Dev Neurosci 1991; 13: 327-30.
110. 110 Schellenberg F, Beuge F, Bourdin C, Bourre JM, Weill J. Alcohol intoxication and sialic acid in erythrocyte membrane and in serum transferrin. Pharmacol Biochem Behav 1991; 39: 443-7.
111. 111 Sillanaukee P, Seppä K, Mårtensson O. The use of sialic acid determination for alcohol consumption. European patent 95922064.1.
112. 112 Sillanaukee P, Pönniö M, Seppä K. Sialic acid - new potential marker of alcohol abuse. Alcoholism Clin Exp Res 1999 (in press).
113. 113 Lieber CS. Medical disorders of alcoholism. N Engl J Med 1995; 333: 1058-65.
114. 114 O'Connor PG, Schottenfeld RS. Patients with alcohol problems. N Engl J Med 1998; 338: 592-602.
115. 115 Ozben T. Elevated serum and urine sialic acid levels in renal diseases. Ann Clin Biochem 1991; 28: 44-8.
116. 116 Stefenelli N, Klotz H, Engel A, Bauer P. Serum sialic acid in malignant tumors, bacterial infections and chronic liver diseases. J Cancer Res Clin Oncol 1985; 109: 55-9.
117. 117 Cardenas A, Bernard AM, Lauwerys RR. Disturbance of sialic acid metabolism by chronic cadmium exposure and its relation to proteinuria. Toxicol Appl Pharmacol 1991; 108: 547-58.
118. 118 du Toit D, Bornman MS, van der Merwe MP, du Plessis DJ. High seminal sialic acid concentrations in patients with severe teratozoospermia. Arch Androl 1992; 28: 177-9.
119. 119 Lamba PA, Pandey PK, Sarin GS, Marthur MD. Serum sialic acid levels in patients with sympathetic ophthalmitis. Acta Ophthalmol 1993; 71: 833-5.
120. 120 Lam S, Tessler HH, Farber MD, et al. Elevated serum sialic acid in idiopathic acute iridocyclitis. Acta Opthalmol 1993; 71: 119-21.
121. 121 Crook MA, Tutt P, Simpson H, Pickup JC. Serum sialic acid and acute phase proteins in type 1 and type 2 diabetes mellitus. Clin Chim Acta 1993; 219: 131-8.
122. 122 Ozben T, Nacitarhan S, Tuncer N. Plasma and urine sialic acid in non-insulin dependent diabetes mellitus. Ann Clin Biochem 1995; 32: 303-6.
123. 123 Konukoglu D, Ackay T, Celik C, Erozenci A. Urinary excretion of sialic acid in patients with bladder tumors. Cancer Lett 1995; 94: 97-100.